Quotient Clinical, the Translational Pharmaceutics company, is holding a series of formulation development and drug delivery seminars this June and July.
The seminars will take place at major life science hubs in the UK and USA, and will address the most pressing challenges currently faced by pharmaceutical and biotechnology companies in early drug development.
Starting in San Diego, the series will bring together a team of industry experts for insightful presentations and discussions, giving attendees the chance to explore innovative approaches for optimizing drug product formulations; from strategies and technologies to enhance oral bioavailability to the use of spray drying to overcome solubility challenges.
Speakers include prominent biotech consultant and entrepreneur Nick Barker and Richard Johnson, CEO and Founder of Upperton Ltd, and they will be joined by representatives from Quotient Clinical’s experienced scientific team, including John McDermott, Dr Kieran Crowley and Dr Kevin Kane. The presentations and discussions will be followed by a complimentary lunch, providing an informal networking opportunity to further examine these issues with leading industry figures.
For further information, please contact:
Robin BodicoatMarketing Director
Quotient Clinical
Tel: +44 (0)115 931 5102
robin.bodicoat@quotientclinical.com
About Quotient Clinical
Quotient Clinical offers unique services – based on its Translational Pharmaceutics® platform – that integrate formulation development, real-time drug product manufacturing and clinical testing, significantly reducing the time and cost of bringing a drug to market.For more than 25 years, Quotient Clinical has brought innovation to drug product development programs for pharmaceutical and biotechnology customers worldwide. The company is based in purpose-built, fully integrated facilities in the UK, where formulation development, real-time GMP manufacturing and early clinical trials are performed in the same facility. It employs over 320 staff, offering a full range of support services, from study set-up right through to data analysis and reporting. Quotient Clinical was recently acquired by specialist healthcare investor GHO Capital who will support the future development of the company.
kdm communications limited
Cressner House, Suite 3,12 Huntingdon Street, St Neots, PE19 1BG
Tel +44.1480.405333
Fax +44.1480.477833
www.kdm-communications.com
